199 related articles for article (PubMed ID: 14978230)
1. Valproic acid inhibits angiogenesis in vitro and in vivo.
Michaelis M; Michaelis UR; Fleming I; Suhan T; Cinatl J; Blaheta RA; Hoffmann K; Kotchetkov R; Busse R; Nau H; Cinatl J
Mol Pharmacol; 2004 Mar; 65(3):520-7. PubMed ID: 14978230
[TBL] [Abstract][Full Text] [Related]
2. Teratogenic effects mediated by inhibition of histone deacetylases: evidence from quantitative structure activity relationships of 20 valproic acid derivatives.
Eikel D; Lampen A; Nau H
Chem Res Toxicol; 2006 Feb; 19(2):272-8. PubMed ID: 16485903
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide induces angiogenesis and upregulates alpha(v)beta(3) integrin expression on endothelial cells.
Lee PC; Kibbe MR; Schuchert MJ; Stolz DB; Watkins SC; Griffith BP; Billiar TR; Shears LL
Microvasc Res; 2000 Nov; 60(3):269-80. PubMed ID: 11078643
[TBL] [Abstract][Full Text] [Related]
4. Homocysteine inhibits angiogenesis in vitro and in vivo.
Nagai Y; Tasaki H; Takatsu H; Nihei S; Yamashita K; Toyokawa T; Nakashima Y
Biochem Biophys Res Commun; 2001 Mar; 281(3):726-31. PubMed ID: 11237718
[TBL] [Abstract][Full Text] [Related]
5. HB-EGF stimulates eNOS expression and nitric oxide production and promotes eNOS dependent angiogenesis.
Mehta VB; Zhou Y; Radulescu A; Besner GE
Growth Factors; 2008 Dec; 26(6):301-15. PubMed ID: 18925469
[TBL] [Abstract][Full Text] [Related]
6. Visfatin activates eNOS via Akt and MAP kinases and improves endothelial cell function and angiogenesis in vitro and in vivo: translational implications for atherosclerosis.
Lovren F; Pan Y; Shukla PC; Quan A; Teoh H; Szmitko PE; Peterson MD; Gupta M; Al-Omran M; Verma S
Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1440-9. PubMed ID: 19351806
[TBL] [Abstract][Full Text] [Related]
7. Multiple Molecular pathways explain the anti-proliferative effect of valproic acid on prostate cancer cells in vitro and in vivo.
Shabbeer S; Kortenhorst MS; Kachhap S; Galloway N; Rodriguez R; Carducci MA
Prostate; 2007 Jul; 67(10):1099-110. PubMed ID: 17477369
[TBL] [Abstract][Full Text] [Related]
8. Discovery of a benzoxazine derivative promoting angiogenesis in vitro and in vivo.
Dong Z; Cheng Y; Zhao J; Su L; Zhao B; Zhang Y; Zhang S; Miao J
J Cell Physiol; 2010 Apr; 223(1):202-8. PubMed ID: 20049873
[TBL] [Abstract][Full Text] [Related]
9. Induction of osteogenic differentiation of human mesenchymal stem cells by histone deacetylase inhibitors.
Cho HH; Park HT; Kim YJ; Bae YC; Suh KT; Jung JS
J Cell Biochem; 2005 Oct; 96(3):533-42. PubMed ID: 16088945
[TBL] [Abstract][Full Text] [Related]
10. Phenethyl isothiocyanate inhibits angiogenesis in vitro and ex vivo.
Xiao D; Singh SV
Cancer Res; 2007 Mar; 67(5):2239-46. PubMed ID: 17332354
[TBL] [Abstract][Full Text] [Related]
11. 16K-prolactin inhibits activation of endothelial nitric oxide synthase, intracellular calcium mobilization, and endothelium-dependent vasorelaxation.
Gonzalez C; Corbacho AM; Eiserich JP; Garcia C; Lopez-Barrera F; Morales-Tlalpan V; Barajas-Espinosa A; Diaz-Muñoz M; Rubio R; Lin SH; Martinez de la Escalera G; Clapp C
Endocrinology; 2004 Dec; 145(12):5714-22. PubMed ID: 15358675
[TBL] [Abstract][Full Text] [Related]
12. Novel function of ascorbic acid as an angiostatic factor.
Ashino H; Shimamura M; Nakajima H; Dombou M; Kawanaka S; Oikawa T; Iwaguchi T; Kawashima S
Angiogenesis; 2003; 6(4):259-69. PubMed ID: 15166494
[TBL] [Abstract][Full Text] [Related]
13. The histone deacetylase inhibitor NVP-LAQ824 inhibits angiogenesis and has a greater antitumor effect in combination with the vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK222584.
Qian DZ; Wang X; Kachhap SK; Kato Y; Wei Y; Zhang L; Atadja P; Pili R
Cancer Res; 2004 Sep; 64(18):6626-34. PubMed ID: 15374977
[TBL] [Abstract][Full Text] [Related]
14. p21Waf1/Cip1 is a common target induced by short-chain fatty acid HDAC inhibitors (valproic acid, tributyrin and sodium butyrate) in neuroblastoma cells.
Rocchi P; Tonelli R; Camerin C; Purgato S; Fronza R; Bianucci F; Guerra F; Pession A; Ferreri AM
Oncol Rep; 2005 Jun; 13(6):1139-44. PubMed ID: 15870934
[TBL] [Abstract][Full Text] [Related]
15. Valproic acid inhibits proliferation of human coronary vascular cells (SI/MPL-ratio: 0.5): a novel candidate for systemic and local therapy of postinterventional restenosis.
Voisard R; Krebs R; Baur R; Hombach V
Coron Artery Dis; 2010 Aug; 21(5):286-91. PubMed ID: 20508518
[TBL] [Abstract][Full Text] [Related]
16. Modulation of adhesion and growth of colon and pancreatic cancer cells by the histone deacetylase inhibitor valproic acid.
Jones J; Bentas W; Blaheta RA; Makarevic J; Hudak L; Wedel S; Probst M; Jonas D; Juengel E
Int J Mol Med; 2008 Sep; 22(3):293-9. PubMed ID: 18698487
[TBL] [Abstract][Full Text] [Related]
17. Cigarette smoke exposure impairs VEGF-induced endothelial cell migration: role of NO and reactive oxygen species.
Michaud SE; Dussault S; Groleau J; Haddad P; Rivard A
J Mol Cell Cardiol; 2006 Aug; 41(2):275-84. PubMed ID: 16806264
[TBL] [Abstract][Full Text] [Related]
18. Inhibitors of histone deacetylation downregulate the expression of endothelial nitric oxide synthase and compromise endothelial cell function in vasorelaxation and angiogenesis.
Rössig L; Li H; Fisslthaler B; Urbich C; Fleming I; Förstermann U; Zeiher AM; Dimmeler S
Circ Res; 2002 Nov; 91(9):837-44. PubMed ID: 12411399
[TBL] [Abstract][Full Text] [Related]
19. Antioxidants inhibit human endothelial cell functions through down-regulation of endothelial nitric oxide synthase activity.
Polytarchou C; Papadimitriou E
Eur J Pharmacol; 2005 Mar; 510(1-2):31-8. PubMed ID: 15740722
[TBL] [Abstract][Full Text] [Related]
20. Increased replication of human cytomegalovirus in retinal pigment epithelial cells by valproic acid depends on histone deacetylase inhibition.
Michaelis M; Suhan T; Reinisch A; Reisenauer A; Fleckenstein C; Eikel D; Gümbel H; Doerr HW; Nau H; Cinatl J
Invest Ophthalmol Vis Sci; 2005 Sep; 46(9):3451-7. PubMed ID: 16123451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
